OBJECTIVE: Pulmonary arterial hypertension (PAH) is a rare condition, with an incidence of
15-50 cases per million annually. Available studies demonstrate that despite the longer …

Background The increasing survival of patients with pulmonary arterial hypertension (PAH)
has shifted attention towards the disease burden that PAH imposes on patients and …

Recent guidelines on cardiovascular disease prevention suggest multimodal behavioral
interventions for psychosocial risk factors and referral for psychotherapy in the case of …

Background: Pulmonary arterial hypertension (PAH) is a chronic illness that impairs physical
function and leads to right-sided heart failure and premature death. There is limited …

Pulmonary arterial hypertension (PAH) is a chronic, symptomatic, life-threatening illness;
however, it is complex, with variable expression regarding impact on quality of life (QOL) …

Objectives To investigate the patient's experience of the trajectory to receiving a diagnosis of
pulmonary arterial hypertension (PAH) and inform the provision of care for this patient group …

Background Pulmonary arterial hypertension (PAH), as a life-threatening disease with no
efficient cure, may impose a tremendous economic burden on patients and healthcare …

Objective Pulmonary arterial hypertension (PAH) is a rare and life-threatening disease well-
marked by under diagnosis, delayed diagnosis and atypical treatments. Few data are …

Background Pulmonary arterial hypertension (PAH) is characterized by elevated pulmonary
artery pressures leading to right heart failure and death. Aims The aim of this study was to …

Background: Pulmonary arterial hypertension (PAH) is a rare disease characterised by a
severe impairment of functional status and quality of life (QoL). Use of rehabilitative …